Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 64

    1.

    A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model.

    Islam R, Yang L, Sah M, Kannan K, Anamani D, Vijayan C, Kwok J, Cantino ME, Beal MF, Fridell YW.

    Neurobiol Dis. 2012 Apr;46(1):137-46. Epub 2012 Jan 13.

    PMID:
    22266335
    [PubMed - in process]
    2.

    MicroRNAs in Parkinson's disease.

    Mouradian MM.

    Neurobiol Dis. 2012 May;46(2):279-84. Epub 2012 Jan 5.

    PMID:
    22245218
    [PubMed - in process]
    3.

    Animal models of the non-motor features of Parkinson's disease.

    McDowell K, Chesselet MF.

    Neurobiol Dis. 2012 Jun;46(3):597-606. Epub 2012 Jan 3.

    PMID:
    22236386
    [PubMed - in process]
    4.

    Psychosis, apathy, depression and anxiety in Parkinson's disease.

    Gallagher DA, Schrag A.

    Neurobiol Dis. 2012 Jun;46(3):581-9. Epub 2012 Jan 3.

    PMID:
    22245219
    [PubMed - in process]
    5.

    Use of viral vectors to create animal models for Parkinson's disease.

    Löw K, Aebischer P.

    Neurobiol Dis. 2011 Dec 29. [Epub ahead of print]

    PMID:
    22227451
    [PubMed - as supplied by publisher]
    6.

    Olfaction in Parkinson's disease and related disorders.

    Doty RL.

    Neurobiol Dis. 2012 Jun;46(3):527-52. Epub 2011 Dec 20.

    PMID:
    22192366
    [PubMed - in process]
    7.

    Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.

    Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H.

    Neurobiol Dis. 2012 Mar;45(3):1018-30. Epub 2011 Dec 16.

    PMID:
    22198569
    [PubMed - in process]
    8.

    Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.

    Neurobiol Dis. 2012 Mar;45(3):1051-67. Epub 2011 Dec 14.

    PMID:
    22198503
    [PubMed - in process]
    9.

    Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism.

    Delaville C, Chetrit J, Abdallah K, Morin S, Cardoit L, De Deurwaerdère P, Benazzouz A.

    Neurobiol Dis. 2012 Feb;45(2):763-73. Epub 2011 Nov 4.

    PMID:
    22079236
    [PubMed - indexed for MEDLINE]
    10.

    Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis.

    Jain S, Goldstein DS.

    Neurobiol Dis. 2012 Jun;46(3):572-80. Epub 2011 Nov 4.

    PMID:
    22094370
    [PubMed - in process]
    11.

    Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease.

    Verhaar R, Drukarch B, Bol JG, Jongenelen CA, Musters RJ, Wilhelmus MM.

    Neurobiol Dis. 2012 Mar;45(3):839-50. Epub 2011 Oct 25.

    PMID:
    22051113
    [PubMed - in process]
    12.

    Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain.

    Cederfjäll E, Sahin G, Kirik D.

    Neurobiol Dis. 2011 Oct 25. [Epub ahead of print]

    PMID:
    22048069
    [PubMed - as supplied by publisher]
    13.

    Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.

    Cersosimo MG, Benarroch EE.

    Neurobiol Dis. 2012 Jun;46(3):559-64. Epub 2011 Oct 25.

    PMID:
    22048068
    [PubMed - in process]
    14.

    Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain.

    Kells AP, Forsayeth J, Bankiewicz KS.

    Neurobiol Dis. 2011 Oct 14. [Epub ahead of print]

    PMID:
    22019719
    [PubMed - as supplied by publisher]
    15.

    Pathophysiology of bladder dysfunction in Parkinson's disease.

    Sakakibara R, Tateno F, Kishi M, Tsuyuzaki Y, Uchiyama T, Yamamoto T.

    Neurobiol Dis. 2012 Jun;46(3):565-71. Epub 2011 Oct 10.

    PMID:
    22015601
    [PubMed - in process]
    16.

    Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate.

    Moran A, Stein E, Tischler H, Bar-Gad I.

    Neurobiol Dis. 2012 Jan;45(1):583-90. Epub 2011 Oct 7.

    PMID:
    22001603
    [PubMed - in process]
    17.

    Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

    Botta-Orfila T, Tolosa E, Gelpi E, Sànchez-Pla A, Martí MJ, Valldeoriola F, Fernández M, Carmona F, Ezquerra M.

    Neurobiol Dis. 2012 Jan;45(1):462-8. Epub 2011 Sep 16.

    PMID:
    21946334
    [PubMed - in process]
    18.

    A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease.

    Pouclet H, Lebouvier T, Coron E, des Varannes SB, Rouaud T, Roy M, Neunlist M, Derkinderen P.

    Neurobiol Dis. 2012 Jan;45(1):305-9. Epub 2011 Aug 22.

    PMID:
    21878391
    [PubMed - in process]
    19.

    Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

    Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM.

    Neurobiol Dis. 2012 Jan;45(1):188-95. Epub 2011 Aug 10.

    PMID:
    21856424
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk